AGYGX
Price
$12.66
Change
-$0.21 (-1.63%)
Updated
Jul 13 closing price
Net Assets
550.93M
RNPCX
Price
$71.64
Change
-$0.96 (-1.32%)
Updated
Jul 13 closing price
Net Assets
170.23B
Interact to see
Advertisement

AGYGX vs RNPCX

AGYGX vs RNPCX Comparison Chart in %
View a ticker or compare two or three
VS
AGYGX vs. RNPCX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AGYGX is a Buy and RNPCX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RNPCX has more cash in the bank: 170B vs. AGYGX (551M). RNPCX pays higher dividends than AGYGX: RNPCX (0.70) vs AGYGX (0.38). AGYGX was incepted earlier than RNPCX: AGYGX (9 years) vs RNPCX (24 years). RNPCX (1.05) is less costly to investors than AGYGX (0.75). AGYGX is a more actively managed with annual turnover of: 68.00 vs. RNPCX (23.00). AGYGX has a lower initial minimum investment than RNPCX: AGYGX (0) vs RNPCX (250). RNPCX annual gain was more profitable for investors over the last year : 6.93 vs. AGYGX (1.27). RNPCX return over 5 years is better than : 11.29 vs. AGYGX (-17.19).
AGYGXRNPCXAGYGX / RNPCX
Total Expense Ratio0.751.0571%
Annual Report Gross Expense Ratio0.751.0571%
Fund Existence9 years24 years-
Gain YTD6.3645.152124%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets551M170B0%
Annual Yield % from dividends0.380.7054%
Returns for 1 year1.276.9318%
Returns for 3 years15.3232.6547%
Returns for 5 years-17.1911.29-152%
Returns for 10 yearsN/A103.71-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HIEMX7.77N/A
N/A
Virtus SGA Emerging Markets Equity I
VESIX47.21N/A
N/A
Vanguard European Stock Instl
FSGAX48.69N/A
N/A
Franklin Small-Mid Cap Growth Adv
FBTDX177.71N/A
N/A
Franklin Biotechnology Discovery C
TSLTX6.45N/A
N/A
Transamerica Small Cap Value I3